Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Splint, wax, or mud: which eases trigger finger best?

NCT ID NCT07256522

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests three simple treatments for trigger finger: a finger splint, warm paraffin wax baths, and peloidotherapy (mud therapy), all combined with home exercises. Sixty adults with mild to moderate trigger finger will be randomly assigned to one of the three groups for six weeks. Researchers will measure pain, finger locking, and hand function to see which approach works best.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
finger splint, paraffin bath, peloidotherapy
What this could lead to
If successful, this could show which non-invasive treatment works best for easing trigger finger symptoms, helping patients avoid injections or surgery.
What could go wrong
This is a small, early-stage study with only 60 participants. Results may not apply to everyone, and some treatments may not provide lasting relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being between 18 and 75 years of age and willing to participate in the study * Having a diagnosis of idiopathic single trigger finger, Grade 2-3 Exclusion Criteria: * Patients with triggering in more than one finger * Patients with triggering at the A3 pulley or with Grade 1 or Grade 4 trigger finger * Patients with thumb (pollex) trigger finger * Patients who have undergone any injection or interventional procedure (release surgery) for trigger finger within the past 6 months * Patients who have received physical therapy for the hand within the past 6 months * Patients currently using corticosteroids or nonsteroidal anti-inflammatory drugs (NSAIDs) * Patients with inflammatory or autoimmune rheumatologic diseases such as rheumatoid arthritis, systemic lupus erythematosus, gout, or psoriatic arthritis * Patients with other musculoskeletal disorders (e.g., carpal tunnel syndrome, de Quervain's tenosynovitis, symptomatic hand osteoarthritis, or Dupuytren's contracture) or neurological diseases (e.g., stroke-related hemiparesis, spinal cord injury, brachial plexus injury, multiple sclerosis, or Parkinsonism) affecting the same hand * Patients with musculoskeletal disorders causing pain and/or limitation in the proximal upper extremity on the affected side (e.g., periarthritis, lateral epicondylitis, mononeuropathy, or radiculopathy) * Patients with significant metabolic diseases (e.g., hypothyroidism, Cushing's syndrome, or uncontrolled diabetes) * Patients with any condition that may interfere with treatment, such as open wounds, rashes, local infections, or active malignant disease of the hand * Patients with a history of hand trauma (chronic or repetitive) * Patients unwilling to complete the self-assessment questionnaires either independently or with assistance * Pregnant women

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Efficacy and safety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Konya Beyhekim Training and Research Hospital

    RECRUITING

    Konya, Konya, 42080, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.